2123 POSTER MO19391: an open-label safety study of bevacizumab plus taxane monotherapy or in combination as first-line treatment of patients with locally recurrent or metastatic breast cancer (LR or MBC) Conference Paper uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Identity
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Smith, IE
  • Biganzoli, L
  • Cortes-Funes, H
  • Franke, F
  • Mostafa Kamel, Y
  • Pierga, JY
  • Pritchard, Kathleen
  • Stroyakovs, D
  • Thomssen, C
  • Vinholes, J

publication date

  • September 2007